MATINAS BIOPHARMA HOLDINGS I (MTNB) Stock Analyst Earnings Estimates
NYSEARCA:MTNB - NYSE Arca - US5768103039 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 33.33K -78.95% | 3.188M 9,464.96% | 1.096M -65.62% | -100.00% | 23.053M | 122.49M 431.34% | 161.87M 32.15% | 210.87M 30.27% | 549.49M 160.58% | 619.59M 12.76% | |||
| EBITDA YoY % growth | -24.455M -2.25% | -24.234M 0.90% | -23.373M 3.55% | -24.582M -5.17% | -20.4M 17.01% | 5.1M 125.00% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -24.735M -2.18% | -24.59M 0.59% | -23.766M 3.35% | -22.296M 6.19% | -18.996M 14.80% | -36.492M -92.10% | 9.173M 125.14% | 180.78M 1,870.78% | 236.92M 31.05% | 308.74M 30.31% | 457.1M 48.05% | 518.79M 13.50% | |
| Operating Margin | -74,211.70% | -771.33% | -2,168.43% | N/A | N/A | N/A | 39.79% | 147.59% | 146.36% | 146.41% | 83.19% | 83.73% | |
| EPS YoY % growth | -5.50 8.33% | -5.50 | -5.50 | -4.37 20.63% | -3.06 29.91% | -5.10 -66.67% | 1.02 120.00% | 24.99 2,350.00% | 32.13 28.57% | 41.82 30.16% | 61.20 46.34% | 68.34 11.67% |
All data in USD
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -0.91 9.22% |
| Revenue Q2Q % growth | |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | -5.078M 13.75% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.85 43.33% | -1.08 | 0.23 | 21.01% |
| Q2 2024 Q2Q % growth | -1.00 33.33% | -1.28 | 0.27 | 21.57% |
| Q1 2024 Q2Q % growth | -1.50 | -1.53 | 0.03 | 1.96% |
| Q4 2023 Q2Q % growth | -1.00 | -1.53 | 0.53 | 34.64% |
| Q3 2023 Q2Q % growth | -1.50 | -1.53 | 0.03 | 1.96% |
| Q2 2023 Q2Q % growth | -1.50 | -1.53 | 0.03 | 1.96% |
| Q1 2023 Q2Q % growth | -1.50 | -1.53 | 0.03 | 1.96% |
| Q4 2022 Q2Q % growth | -1.00 33.33% | -1.36 | 0.36 | 26.48% |
| Q3 2022 Q2Q % growth | -1.50 | -1.53 | 0.03 | 1.96% |
| Q2 2022 Q2Q % growth | -1.50 -50.00% | -1.53 | 0.03 | 1.96% |
| Q1 2022 Q2Q % growth | -1.50 | -1.28 | -0.23 | -17.65% |
| Q4 2021 Q2Q % growth | -1.50 | -1.70 | 0.20 | 11.76% |
| Q3 2021 Q2Q % growth | -1.50 | -1.15 | -0.35 | -30.72% |
| Q2 2021 Q2Q % growth | -1.00 33.33% | -1.53 | 0.53 | 34.64% |
| Q1 2021 Q2Q % growth | -1.50 | -1.53 | 0.03 | 1.96% |
| Q4 2020 Q2Q % growth | -1.50 25.00% | -1.43 | -0.07 | -5.04% |
| Q3 2020 Q2Q % growth | -1.50 | -1.70 | 0.20 | 11.76% |
| Q2 2020 Q2Q % growth | -1.50 | -1.62 | 0.12 | 7.13% |
| Q1 2020 Q2Q % growth | -1.50 25.00% | -1.43 | -0.07 | -5.04% |
| Q4 2019 Q2Q % growth | -2.00 | -1.62 | -0.38 | -23.83% |
| Q3 2019 Q2Q % growth | -1.50 | -1.66 | 0.16 | 9.50% |
| Q2 2019 Q2Q % growth | -1.50 | -1.79 | 0.29 | 15.97% |
| Q1 2019 Q2Q % growth | -2.00 | -1.53 | -0.47 | -30.72% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q3 2023 Q2Q % growth | -100.00% | % | ||
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q1 2023 Q2Q % growth | 1.096M | 306K | 790K | 258.17% |
| Q4 2022 Q2Q % growth | 1.063M | 1.122M | -59K | -5.26% |
| Q3 2022 Q2Q % growth | 1.063M | 850.425K | 212.075K | 24.94% |
| Q2 2022 Q2Q % growth | 1.063M | 104.723K | 957.777K | 914.58% |
| Q1 2022 Q2Q % growth | -100.00% | 4.08K | -4.08K | -100.00% |
| Q4 2021 Q2Q % growth | -100.00% | 476.003K | -476.003K | -100.00% |
| Q3 2021 Q2Q % growth | -100.00% | 1.566M | -1.566M | -100.00% |
| Q2 2021 Q2Q % growth | 34.935K | -34.935K | -100.00% | |
| Q1 2021 Q2Q % growth | 33.33K | 25.5K | 7.83K | 30.71% |
| Q4 2020 Q2Q % growth | 62.5K 170.29% | 1.04M | -977.5K | -93.99% |
| Q3 2020 Q2Q % growth | 95.83K 705.06% | 25.092K | 70.738K | 281.91% |
| Q2 2020 Q2Q % growth | -100.00% | 24.888K | -24.888K | -100.00% |
| Q1 2020 Q2Q % growth | 26.724K | -26.724K | -100.00% | |
| Q1 2019 Q2Q % growth | 32.028K | -32.028K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -2866.67% | 4.89% | 4.89% |
| Revenue | N/A | N/A | N/A | N/A |